SLI
2.202,56
PKT
+13,14
PKT
+0,60
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.12.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.12.19 | Givaudan Underperform | Credit Suisse Group | |
| 06.12.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 06.12.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 06.12.19 | Swiss Re kaufen | DZ BANK | |
| 06.12.19 | Swiss Re Sell | UBS AG | |
| 06.12.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 06.12.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.12.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 04.12.19 | UBS buy | Deutsche Bank AG | |
| 04.12.19 | Swiss Re overweight | Barclays Capital | |
| 04.12.19 | Zurich Insurance overweight | Barclays Capital | |
| 03.12.19 | Zurich Insurance Hold | Deutsche Bank AG | |
| 03.12.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 03.12.19 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 02.12.19 | Zurich Insurance Outperform | Credit Suisse Group | |
| 02.12.19 | Roche overweight | Barclays Capital | |
| 28.11.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 28.11.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 28.11.19 | UBS Equal weight | Barclays Capital | |
| 28.11.19 | UBS Underweight | Barclays Capital | |
| 27.11.19 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 27.11.19 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 27.11.19 | Roche Reduce | HSBC | |
| 27.11.19 | Novartis Hold | HSBC | |
| 26.11.19 | Novartis Hold | HSBC | |
| 26.11.19 | Swiss Re Sell | UBS AG | |
| 26.11.19 | Novartis Hold | Deutsche Bank AG | |
| 26.11.19 | Swiss Re Hold | Jefferies & Company Inc. | |
| 25.11.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 25.11.19 | Novartis Neutral | Credit Suisse Group | |
| 25.11.19 | Novartis Neutral | UBS AG | |
| 25.11.19 | Roche buy | UBS AG | |
| 25.11.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 25.11.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 25.11.19 | Novartis buy | Jefferies & Company Inc. | |
| 25.11.19 | Roche buy | Deutsche Bank AG | |
| 25.11.19 | Roche overweight | JP Morgan Chase & Co. | |
| 22.11.19 | UBS Sector Perform | RBC Capital Markets |